These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18381930)

  • 1. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.
    Dallas NA; Samuel S; Xia L; Fan F; Gray MJ; Lim SJ; Ellis LM
    Clin Cancer Res; 2008 Apr; 14(7):1931-7. PubMed ID: 18381930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
    Fonsatti E; Del Vecchio L; Altomonte M; Sigalotti L; Nicotra MR; Coral S; Natali PG; Maio M
    J Cell Physiol; 2001 Jul; 188(1):1-7. PubMed ID: 11382917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.
    Fonsatti E; Altomonte M; Nicotra MR; Natali PG; Maio M
    Oncogene; 2003 Sep; 22(42):6557-63. PubMed ID: 14528280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy.
    Nassiri F; Cusimano MD; Scheithauer BW; Rotondo F; Fazio A; Yousef GM; Syro LV; Kovacs K; Lloyd RV
    Anticancer Res; 2011 Jun; 31(6):2283-90. PubMed ID: 21737653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
    Lebrin F; Mummery CL
    Trends Cardiovasc Med; 2008 Jan; 18(1):25-32. PubMed ID: 18206806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers.
    Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
    Pathol Int; 2006 Dec; 56(12):717-23. PubMed ID: 17096728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD105 is important for angiogenesis: evidence and potential applications.
    Duff SE; Li C; Garland JM; Kumar S
    FASEB J; 2003 Jun; 17(9):984-92. PubMed ID: 12773481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.
    Wikström P; Lissbrant IF; Stattin P; Egevad L; Bergh A
    Prostate; 2002 Jun; 51(4):268-75. PubMed ID: 11987155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endoglin (CD105)--a target for visualization and anti-angiogenic therapy for malignant tumors].
    Smirnov IV; Gryazeva IV; Samoilovich MP; Klimovich VB
    Vopr Onkol; 2015; 61(6):898-907. PubMed ID: 26995976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoglin in angiogenesis and vascular diseases.
    ten Dijke P; Goumans MJ; Pardali E
    Angiogenesis; 2008; 11(1):79-89. PubMed ID: 18283546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific expression of endoglin (CD105) in endothelial cells of intratumoral blood and lymphatic vessels in pancreatic cancer.
    Yoshitomi H; Kobayashi S; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Miyazaki M
    Pancreas; 2008 Oct; 37(3):275-81. PubMed ID: 18815549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(4A):2701-10. PubMed ID: 9703932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.
    Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
    Virchows Arch; 2006 Feb; 448(2):127-34. PubMed ID: 16177881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD105 prevents apoptosis in hypoxic endothelial cells.
    Li C; Issa R; Kumar P; Hampson IN; Lopez-Novoa JM; Bernabeu C; Kumar S
    J Cell Sci; 2003 Jul; 116(Pt 13):2677-85. PubMed ID: 12746487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
    Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
    Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
    Netto GC; Bleil CB; Hilbig A; Coutinho LM
    Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
    Pappa CA; Alexandrakis MG; Boula A; Psarakis FE; Kolovou A; Bantouna V; Stavroulaki E; Tsirakis G
    Hematol Oncol; 2013 Dec; 31(4):201-5. PubMed ID: 23576184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.
    Fonsatti E; Sigalotti L; Arslan P; Altomonte M; Maio M
    Curr Cancer Drug Targets; 2003 Dec; 3(6):427-32. PubMed ID: 14683500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.